MPA療法が奏効し生児を得た後に再発を認めた子宮体癌の1例

概要

論文の詳細を見る
A 29-year-old woman, who was diagnosed as having stage a endometrioid adenocarcinoma of the uterine body, orally received medroxyprogesterone acetate(MPA)at 600 mg/day for 27 weeks, and the lesion was determined to be eliminated. This patient became pregnant 2 months after the completion of MPA therapy, and she was delivered of a live newborn. After that, she relapsed and again received MPA therapy. This therapy is thought to be extremely effective if patient selection is made based on precise histopathological diagnosis and staging, although great care should be given to watch for postpartum recurrence.
社団法人日本産科婦人科学会の論文
2000-12-01